Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis

被引:483
作者
Jimenez, JJ
Jy, W
Mauro, LM
Soderland, C
Horstman, LL
Ahn, YS
机构
[1] Univ Miami, Sch Med, Wallace H Coulter Platelet Lab, Div Hematol Oncol, Miami, FL 33152 USA
[2] Appl Cell Biol Res Inst, Kirkland, WA USA
关键词
endothelial microparticles; activation; apoptosis; endothelial cells; phenotype; adhesion molecules;
D O I
10.1016/S0049-3848(03)00064-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endothelial cells (EC) shed endothelial microparticles (EMP) in activation and apoptosis. Objectives: We compared the antigenic expression of EMP species released during activation as compared to apoptosis, in three cell lines. Methods: EC from renal and brain microvascular (MiVEC) and coronary macrovascular (MaVEC) origin were incubated with TNF-alpha to induce activation, or deprived of growth factors to induce apoptosis. Antigens expressed on EMP and EC were assayed flow cytometrically and included constitutive markers (CD31, CD51/61, CD105), inducible markers (CD54, CD62E and CD106), and annexin V binding. Results: It was found that in apoptosis, constitutive markers in EMP were markedly increased (CD31>CD105), with a concomitant decrease in expression in EC. Annexin V EC surface binding and annexin V+ EMP were more sharply increased in apoptosis than in activation. In contrast, in activation, inducible markers in EMP were markedly increased in both EMP and EC (CD62E>CD54>CD 106). Coronary MaVEC released significantly less EMP than MiVEC. Conclusion: EC release qualitatively and quantitatively distinct EMP during activation compared to apoptosis. Analysis of EMP phenotypic signatures may provide clinically useful information on the status of the endothelium. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 29 条
  • [1] Bernai-Mizrachi L, 2000, BLOOD, V96, p270A
  • [2] Apoptotic vascular endothelial cells become procoagulant
    Bombeli, T
    Karsan, A
    Tait, JF
    Harlan, JM
    [J]. BLOOD, 1997, 89 (07) : 2429 - 2442
  • [3] Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408
  • [4] Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction
    Boulanger, CM
    Scoazec, A
    Ebrahimian, T
    Henry, P
    Mathieu, E
    Tedgui, A
    Mallat, Z
    [J]. CIRCULATION, 2001, 104 (22) : 2649 - 2652
  • [5] CARLOS TM, 1994, BLOOD, V84, P2068
  • [6] Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
    CasciolaRosen, L
    Rosen, A
    Petri, M
    Schlissel, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1624 - 1629
  • [7] TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS
    COLLINS, T
    READ, MA
    NEISH, AS
    WHITLEY, MZ
    THANOS, D
    MANIATIS, T
    [J]. FASEB JOURNAL, 1995, 9 (10) : 899 - 909
  • [8] In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
    Combes, V
    Simon, AC
    Grau, GE
    Arnoux, D
    Camoin, L
    Sabatier, F
    Mutin, M
    Sanmarco, M
    Sampol, J
    Dignat-George, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) : 93 - 102
  • [9] Freyssinet JM, 1999, THROMB HAEMOSTASIS, V82, P727
  • [10] FUNCTIONAL-HETEROGENEITY OF VASCULAR ENDOTHELIAL-CELLS - COMMENTARY
    GERRITSEN, ME
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (17) : 2701 - 2711